Compare CDNA & ATHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | ATHM |
|---|---|---|
| Founded | 1998 | 2008 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical Specialities | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | 2007 | 2013 |
| Metric | CDNA | ATHM |
|---|---|---|
| Price | $66.83 | $21.01 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 13 |
| Target Price | ★ $58.83 | $21.40 |
| AVG Volume (30 Days) | ★ 1.0M | 371.3K |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 8.42% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.13 | N/A |
| Revenue | ★ $48,324,000.00 | N/A |
| Revenue This Year | $30.36 | N/A |
| Revenue Next Year | $6.23 | $1.59 |
| P/E Ratio | $30.04 | ★ $12.13 |
| Revenue Growth | ★ 18.93 | N/A |
| 52 Week Low | $13.95 | $15.57 |
| 52 Week High | $65.50 | $29.07 |
| Indicator | CDNA | ATHM |
|---|---|---|
| Relative Strength Index (RSI) | 78.88 | 43.68 |
| Support Level | $17.26 | $20.74 |
| Resistance Level | N/A | $22.24 |
| Average True Range (ATR) | 2.87 | 0.52 |
| MACD | 0.90 | -0.01 |
| Stochastic Oscillator | 99.39 | 44.54 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Founded in 2008 as a media content platform, Autohome is the leading online automobile platform in China, ranking first among automotive service platforms in terms of mobile daily active users, according to QuestMobile. Through its two websites, autohome.com.cn and che168.com, Autohome delivers comprehensive, independent, and interactive content and tools to automobile consumers as well as a full suite of services to automakers and dealers. According to iResearch, the company was the largest online automotive advertising and lead-generation service provider in China's online auto platform media advertising market, in terms of media services and lead-generation revenue.